Sanofi will ensure that a potential vaccine against Covid-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday. "There will be no particular advance given to any country," Serge Weinberg told France 2 television. "We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France," he said. Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against Covid-19, the illness caused by the new coronavirus. The group's chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access. "The comments of our CEO have been altered. We consider vaccines as a common good," Weinberg said. Mr Hudson said earlier this week that the US would likely be first in line if Sanofi succeeds in developing a vaccine because the country was the first to fund the French company’s research. The US, which expanded a vaccine partnership with the company in February, expects “that if we’ve helped you manufacture the doses at risk, we expect to get the doses first,” Mr Hudson said.